Form 4: Director Georgia Melenikiotou Increases INSP Stake

Inspire Medical Systems director Georgia Melenikiotou acquired 307 shares of common stock in lieu of cash director fees.

Summary

• Director Georgia Melenikiotou acquired 307 shares of Inspire Medical Systems (INSP) common stock.
• The transaction occurred on April 15, 2026, at a price of $52.07 per share.
• The acquisition was made in lieu of cash compensation under the company's Non-Employee Director Compensation Policy.
• Following this transaction, the director's total beneficial ownership stands at 4,473 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director alignment with shareholder interests through equity-based compensation.
• Demonstrates confidence in the company's long-term value by opting for stock over cash fees.

Negatives

• None identified; this is a standard compensatory transaction.

Risks

• General market risks associated with holding equity in a medical device company.

Future Outlook

Not applicable as this is a routine disclosure of director compensation.

Industry Context

StockSavvy.ai notes that it is common practice for medical technology companies to offer equity-based compensation to board members to ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The practice of paying director fees in stock is consistent with standard corporate governance practices for mid-cap medical device firms.

Stakeholder Impact

• Minimal impact on shareholders; reflects standard director compensation practices.

Next Steps

• No further actions required by the reporting person.

Key Dates

Keywords

Inspire Medical Systems, INSP, Insider Trading, Form 4, Director Compensation, Equity Ownership